The MitraClip procedure expands the treatment options for selected patients with MR, especially those who are not candidates for invasive open heart surgery. The procedure allows doctors to use catheter-based technology to repair the mitral valve through a groin puncture without requiring patients to undergo cardiopulmonary bypass or the need for traditional chest incisions. The procedure shortens recovery time and ultimately improves quality of life for those experiencing life-altering symptoms like fatigue and shortness of breath.
Saint Thomas Heart late in 2016 reached a milestone in performing its 100th MitraClip procedure and is one of one of just 13 Heart Centers, of approximately 240 Heart Centers nationwide, to reach this benchmark. Approximately three years ago, Saint Thomas Heart was the first cardiac program in Tennessee to offer the MitraClip as part of a national clinical trial for patients with congestive heart failure and MR, which is the most common type of heart valve insufficiency in the United States.
“We have a definitive vision for Saint Thomas Heart of providing the most comprehensive treatment options and highest quality of care for our patients,” said Dr. Andrew Morse, MD. “Our Structural Heart program expands the range of options to patients who previously had very limited to no options for their heart disease. The MitraClip is just one of multiple options we have at our disposal today to help our patients return to their normal lives and extend their longevity and quality of life.”